treme C terminus of the 4E-BPs [28]. The TOS motif of phorylation sites was also detected in U2OS cells (Figure 1C). S6K1 functions to receive mTOR signals, as mutagenic inactivation of this motif mimics the effect of rapamycin
To rule out the possibility that the inhibitory effect of the TOS motif mutant (4E-BP1-F114A) on Ser65 and on S6K1 phosphorylation. S6K1 mutations that overcome the inhibitory effect of the nonfunctional TOS motif Thr70 phosphorylation could be a secondary consequence of reduced phosphorylation of the priming sites render S6K1 resistant to the inhibitory effect of amino acid withdrawal and to rapamycin. We have also pre-(Thr37/46), we compared the phosphorylation of Ser65 and Thr70 in wild-type and 4E-BP1-F114A, which consented preliminary data that supports the finding that mutation of Phe114 to Ala in the 4E-BP1 TOS motif tain acidic mutations in the priming sites Thr37/46 (4E-BP1-T37/46E) to mimic Thr37/46 phosphorylation. It has (FEMDI) significantly inhibits insulin-stimulated phosphorylation of 4E-BP1 [28] .
been reported that mutation of Thr37/46 to glutamic residues (4E-BP1-T37/46E) partially restores phosphorHere, we analyze in greater detail the mechanism by which the TOS motif mediates 4E-BP1 phosphorylation ylation of Ser65 and Thr70, whereas mutation of Thr37/ 46 to alanines abolishes phosphorylation of Ser65 and and function. We show that the TOS motif is required for phosphorylation of 4E-BP1 in vitro and in vivo at Thr70 [15] . Phosphorylation of Ser65 and Thr70 in the TOS motif mutant containing acidic Thr37/46 mutations all the identified mTOR-regulated sites. The inability of mTOR to regulate 4E-BP1 phosphorylation in a TOS (4E-BP1-F114A) was significantly less than in a 4E-BP1 mutant with the acidic substitutions for Thr37/46 but motif mutant (F114A) correlates with the inability of raptor to interact with 4E-BP1. Importantly, overexpression with a functional TOS motif; this finding suggests that the TOS motif is required for efficient phosphorylation of 4E-BP1 (F114A) reduces cell size, similar to that observed when the dominant-inhibitory 4E-BP1 mutant of Ser65 and Thr70 even when 4E-BP1 is primed by phosphorylation at Thr37/46. Therefore, the TOS motif (T37/46A) was overexpressed [2] . These results elucidate the mechanism by which mTOR controls the phosis required for mTOR- Figure 1A) , we analyzed the phosphorylation of the nonfunctional TOS motif-containing mutant, 4E-BP1-F114A, TOS motif is required for 4E-BP1 regulation by the mTOR/raptor complex, we cotransfected HA-tagged by employing various 4E-BP1 phospho-specific antibodies. Basal and insulin-stimulated Thr37/46 phos-4E-BP1 and myc-tagged raptor in HEK293E cells. The TOS motif mutant 4E-BP1 (F114A) failed to coimmunophorylation was reduced in the 4E-BP1-F114A mutant protein when compared to wild-type 4E-BP1 in HEK293E cells precipitate with raptor, whereas wild-type 4E-BP1 coimmunoprecipitated, as previously reported (Figures 2A,  (Figure 1B ). The F114A mutation had a more pronounced inhibitory effect on phosphorylation of the later 4E-BP1 2B, and 2D; [26]), indicating that the TOS motif in 4E-BP1 is required for its binding to raptor. The inability of phosphorylation sites Thr70 and Ser65 ( Figure 1B) , of which residual phosphorylation was only detected on 4E-BP1-F114A to bind to raptor is not a consequence of its hypophosphorylated status, as the similarly hypolonger film exposures (data not shown). Therefore, the TOS motif is required for efficient 4E-BP1 phosphorylaphosphorylated 4E-BP1-T37/46A mutant bound raptor as efficiently as wild-type 4E-BP1 (Figure 2A ). We have tion at all mTOR-regulated sites. The residual phosphorylation of Thr37/46 ( Figures 1B and 1C) . Binding of both wild-type and 4E-BP1-F114A to eIF4E was wild-type 4E-BP1 associated with eIF4E, which was abrogated upon insulin stimulation but was recovered abrogated by Y54A/L59A mutations (Figure 4 ). These data suggest that 4E-BP1-F114A binds to eIF4E specifiwhen cells were pretreated with rapamycin, as expected (Figure 4) . The 4E-BP1-F114A mutant displayed stronger cally via the defined eIF4E binding site and therefore functions as an inhibitor of eIF4E. Similar data were association to eIF4E than wild-type 4E-BP1 in serumstarved or rapamycin-treated HEK293E cells; this findobserved by using U2OS cells (data not shown). ing is consistent with decreased phosphorylation on the 4E-BP1-F114A mutant ( Figures 1B, 1C, and 4) termine whether TOS-mediated 4E-BP1 phosphorylation by the mTOR/raptor complex is important for the control of cell growth, we tested whether overexpression of 4E-BP1-F114A would reduce the size of proliferating U2OS cells. We used U2OS cells for this study as their cell size is fairly homogenous and they have been well characterized for cell size regulation by mTOR signaling [2] . Furthermore, we have shown that the regulation of 4E-BP1 phosphorylation is similar in U2OS and HEK293 cells (Figures 1B and 1C) . The relative size of G 1 phase cells was measured by flow cytometry with the parameter forward scatter-height. We first compared the FSC-H histogram of cells transfected with pACTAG-2 vector control to those treated with rapa- Graphical representation of the same experiment whereby (Figures 2A, 2B, and 2D ) and is efficiently raptor, which in turn recruits mTOR to the 4E-BP1/raptor complex. At this time, we do not know whether 4E-BP1 phosphorylated by mTOR in vitro (Figure 3A) , indicating that the TOS motif is required for 4E-BP1 phosphoryladirectly binds to raptor or whether the binding is indirect The RAIP motif in the N terminus of 4E-BP1 and 4E-BP2 has been found to be critical for 4E-BP1 phosphorynoprecipitate with raptor, resulting in reduced in vitro phosphorylation of 4E-BP1 by mTOR (Figures 2A, 2B , lation on mTOR-regulated sites [37] . In contrast to the TOS motif mutant, which has a more pronounced inhibi-2D, and 3A) and reduced phosphorylation of 4E-BP1 at Thr37/46, Ser65, and Thr70 in vivo (Figures 1B and 1C) . tory effect on the phosphorylation of Ser65 and Thr70, deletion or mutation of the RAIP motif significantly inhibThe high basal phosphorylation of Thr37/46 in serumstarved cells is significantly reduced in the 4E-BP1-its mitogen-stimulated phosphorylation of the priming sites Thr37/46. Therefore, it is likely that the RAIP motif F114A mutant ( Figure 1B) ; this finding suggests that the TOS motif is absolutely required for Thr37/46 phosphormediates phosphorylation of Thr37/46 by a mitogenstimulated kinase. ylation under serum-starved conditions. Under amino acid-rich but serum-starved conditions, mTOR likely The TOS motif on S6K1 was also found to be important for phosphorylation of several structurally diverse sites, forms a constitutively active complex with raptor that directly phosphorylates 4E-BP1 at the Thr37/46 priming and this importance is consistent with the possibility that mTOR also dynamically regulates S6K1 via activation of sites to allow for additional mitogen-stimulated phosphorylation (see model: Figure 6; Figures 1B and 1C) . The existence raptor (data not shown). Unfortunately, this weak interaction makes it experimentally difficult for us to characof a serum-stimulated, mTOR-independent kinase for Thr37/46 has also been previously suggested [19, 36] .
terize the contribution of the S6K1 TOS motif to raptor binding. This difference in raptor binding affinity to S6K1 In contrast, phosphorylation of Ser65 and Thr70 appears to be more dependent on mTOR signaling, since and 4E-BP1 could be caused by the different compositions of mTOR/S6K1/raptor or mTOR/4E-BP1/raptor phosphorylation of these sites in the TOS motif mutant (4E-BP1-F114A) is more strongly reduced under serumcomplexes, with additional molecules found specifically in one or the other complex, or as a result of the exisstarved and insulin-stimulated conditions (Figures 1B  and 1C (Figure 6; [34] ). Phosphorylation of Ser65 and required for 4E-BP1-mediated control of cell size. Over-
